Better Communication And Symptom Assessment Are Key To Promoting Adherence To Long-Te
One in three women taking long-term hormonal (endocrine) therapy for invasive breast cancer stop their treatment before the end of the recommended five-year period, according to a major follow-up study, which reveals that women looked after in specialised oncology units are more likely to continue therapy than those cared for by family doctors.
More... |
All times are GMT -7. The time now is 03:29 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021